ASX:COH - Cochlear Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: A$0.00
  • Forecasted Upside: NaN
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
A$0.00
+0.30 (1.20%)
Get New Cochlear Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for COH and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for COH

Average Price Target: A$0.00
This price target is based on 0 analysts offering 12 month price targets for Cochlear in the last 3 months. The average price target is A$0.00, with a high forecast of A$0.00 and a low forecast of A$10,000,000.00. The average price target represents a NaN upside from the last price of A$0.00.

N/A

The current consensus among 0 polled investment analysts is to n/a stock in Cochlear. This rating has held steady since November 2019, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/25/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/24/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/22/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/20/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/19/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/19/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/18/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/17/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
12/20/2018The Goldman Sachs GroupUpgradeBuy
12/20/2018Deutsche Bank AktiengesellschaftUpgradeBuy
12/20/2018Jefferies Financial GroupSet Price TargetBuy$53.00
(Data available from 6/18/2016 forward)
Cochlear logo
Cochlear Limited provides implantable hearing solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers cochlear implants, including Nucleus 7, Nucleus 6, Nucleus CP802, and Kanso sound processors; and Baha bone conduction implants, such as Baha attract system, Baha connect system, Baha softband, Baha soundarc, Baha 5 sound processor, and Baha sound processor. It also provides Cochlear true wireless accessories comprising mini microphones, phone clips, and TV streamers; Nucleus water-safe accessories; and training and development services. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.
Read More

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

201,277 shs

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

0.48%

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Cochlear?

The following sell-side analysts have issued reports on Cochlear in the last twelve months:
View the latest analyst ratings for COH.

What is the current price target for Cochlear?

0 Wall Street analysts have set twelve-month price targets for Cochlear in the last year. has the lowest price target set, forecasting a price of A$10,000,000.00 for Cochlear in the next year.
View the latest price targets for COH.

What is the current consensus analyst rating for Cochlear?

Cochlear currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for COH.

What other companies compete with Cochlear?

How do I contact Cochlear's investor relations team?

Cochlear's physical mailing address is 1 University Avenue Macquarie University, SYDNEY, NSW 2109, Australia. The company's listed phone number is +61-2-94286555. The official website for Cochlear is www.cochlear.com.